ABA Chemicals

ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing and contract development and manufacturing organization headquartered in Taicang, Jiangsu Province. The business was established in 2006 under the name Suzhou ABA Chemicals and operates as a publicly traded company on the Shenzhen Stock Exchange under ticker 300261. Its activities focus on the development and manufacture of fine chemicals, pharmaceutical intermediates, active pharmaceutical ingredients, and intermediates used in agrochemical production. The company serves pharmaceutical, biotechnology, and agricultural-chemical customers through contract research, process development, and manufacturing capabilities. Its disclosed product and technology areas include unnatural amino acids, pyrazoles, triazoles, azaindoles, and other specialized chemical building blocks. ABA Chemicals has also produced an intermediate used in the manufacture of levetiracetam, an active pharmaceutical ingredient used in medicines for epilepsy. These offerings place the company in the specialist segment of the chemical value chain rather than in branded consumer pharmaceuticals: its role is primarily to supply the molecules, intermediates, and manufacturing services required by other life-science and chemical companies. ABA Chemicals has developed a presence in both pharmaceutical and agrochemical intermediates. In the agrochemical field, it acquired Shanghai Puyi Chemical in order to strengthen and consolidate its position in pesticide-manufacturing intermediates. The company also expanded internationally through its 2017 acquisition of Amino Chemicals, a Malta-based manufacturer of pharmaceutical API intermediates that had been established in 1992 and was part of the Dipharma Group. The transaction built on a longstanding relationship between ABA and Dipharma. According to the available reference material, the two organizations had worked together since the 1980s, with their cooperation helping Dipharma gain access to the Chinese pharmaceutical market. By 2017, ABA Chemicals was described as operating six facilities: three manufacturing sites in Jiangsu Province and three research and development facilities in Shanghai. Its Taicang manufacturing facility held ISO 9001 quality-management, ISO 14001 environmental-management, and OHSAS 18001 occupational-health-and-safety certifications as of 2016. This combination of production capacity, research infrastructure, and certification supported the company's positioning as an integrated supplier for customers requiring specialized chemical development and commercial-scale manufacturing. The available public material does not provide enough information to describe a consumer-facing brand strategy, a complete current product catalogue, present-day management, or the company's latest ownership and operating status in detail. ABA Chemicals is best understood as a business-to-business specialty-chemicals and life-sciences manufacturing company whose competitive role comes from technical synthesis, regulated production, intermediate supply, and international customer relationships.

ABA Chemicals is a Chinese specialty-chemicals manufacturer and contract development and manufacturing organization. The company was founded in 2006 as Suzhou ABA Chemicals and later became known publicly as ABA Chemicals or Abachem. From its base in Taicang, Jiangsu Province, it developed a business serving other companies rather than selling finished consumer medicines or agricultural products under a broad retail brand. Its core activities consist of developing and manufacturing fine chemicals, pharmaceutical intermediates, active pharmaceutical ingredients, and agrochemical intermediates. The company also supplies specialized chemical building blocks, including unnatural amino acids, pyrazoles, triazoles, and azaindoles. These classes of compounds are used in pharmaceutical and agricultural-chemical research and production. One specifically identified activity is the production of an intermediate for levetiracetam, an API used in epilepsy treatments. ABA's business model combines technical development with manufacturing. This allows customers in the pharmaceutical, biotechnology, and agrochemical sectors to outsource parts of chemical synthesis, process development, and production. The available material characterizes the company as having a broad enough platform to operate across both life-science and agricultural-chemical supply chains, while retaining a focus on specialized rather than commodity chemicals. The company's pharmaceutical relationships also include a long-running connection with Dipharma. ABA and Dipharma had a working partnership dating from the 1980s, before the establishment of ABA Chemicals in its later corporate form. The relationship gave Dipharma access to the Chinese pharmaceutical market and created a basis for subsequent cooperation. In 2017, ABA Chemicals acquired Amino Chemicals, a Malta-based manufacturer of pharmaceutical API intermediates that had been established in 1992 and was a member of the Dipharma Group. This transaction extended ABA's international footprint and strengthened its pharmaceutical-intermediate capabilities outside mainland China. ABA also pursued consolidation in the agrochemical-intermediate market through the acquisition of Shanghai Puyi Chemical. The available reference does not specify the transaction year or financial terms, but describes the acquisition as part of ABA's effort to reinforce its position in pesticide-manufacturing intermediates. By 2017, the company was reported to have six facilities: three manufacturing facilities in Jiangsu Province and three research and development facilities in Shanghai. This network indicates a division between production capacity and research infrastructure, supporting both customer development work and commercial manufacturing. The Taicang manufacturing site had ISO 9001, ISO 14001, and OHSAS 18001 certifications as of 2016, covering quality management, environmental management, and occupational health and safety. ABA Chemicals is listed on the Shenzhen Stock Exchange under ticker 300261. Public reference material identifies its principal location, business areas, facilities, acquisitions, and selected product categories, but does not provide a sufficiently detailed account of later corporate developments, current executives, current ownership arrangements, or the company's most recent operating performance. Those areas therefore remain open for further verification.

• 2017

  Acquisition of Amino Chemicals

  [1]ABA Chemicalsen.wikipedia.org

  ABA Chemicals acquired Amino Chemicals in Malta, expanding its pharmaceutical API-intermediate manufacturing capabilities and international presence.

• 2017

  Six-facility operating footprint reported

  [1]ABA Chemicalsen.wikipedia.org

  The company was reported to operate three manufacturing facilities in Jiangsu and three research and development facilities in Shanghai.

• 2016

  Taicang facility held multiple management-system certifications

  [1]ABA Chemicalsen.wikipedia.org

  The Taicang manufacturing facility was reported as certified to ISO 9001, ISO 14001, and OHSAS 18001 standards.

• 2012

  China chemical-substance regulatory notification context

  [1]ABA Chemicalsen.wikipedia.org

  ABA Chemicals was referenced in connection with the Chinese Ministry of Environmental Protection's notification process for new chemical substances.

• 2006

  Suzhou ABA Chemicals was founded

  [1]ABA Chemicalsen.wikipedia.org

  The company was established as Suzhou ABA Chemicals, forming the corporate foundation of the later ABA Chemicals business.

• 1980

  Beginning of the ABA–Dipharma working relationship

  [1]ABA Chemicalsen.wikipedia.org

  ABA Chemicals and Dipharma are described as having begun a working partnership in the 1980s, with the cooperation helping Dipharma access the Chinese pharmaceutical market.

A China-based specialist contract development and manufacturing partner for pharmaceutical, biotechnology, and agrochemical companies, with capabilities spanning fine chemicals, intermediates, API-related production, and selected international manufacturing operations.

• Specialty chemicals

  Fine chemicals

  ABA Chemicals provides fine-chemical development and manufacturing for business customers in pharmaceutical, biotechnology, and agrochemical applications. The category covers specialized molecules produced through custom synthesis and process manufacturing rather than high-volume commodity chemicals. The available material presents fine chemicals as one of the company's principal service and product areas.

• Pharmaceutical chemicals

  Pharmaceutical intermediates and API intermediates

  The company manufactures intermediates used in pharmaceutical production, including materials supporting active pharmaceutical ingredient supply chains. Its acquisition of Amino Chemicals in 2017 added an international manufacturing operation focused on pharmaceutical API intermediates. These products are supplied to industrial and pharmaceutical customers rather than marketed as finished consumer medicines.

• Pharmaceutical building blocks

  Unnatural amino acids

  Unnatural amino acids are among ABA Chemicals' identified specialist product areas. They serve as chemical building blocks in pharmaceutical research and synthesis and can be incorporated into more complex molecules. The reference material does not specify individual compounds, formulations, or commercial product names.

• Heterocyclic intermediates

  Pyrazoles, triazoles, and azaindoles

  ABA Chemicals produces or offers pyrazoles, triazoles, and azaindoles as specialized heterocyclic chemical products. These structures are used as intermediates and building blocks in pharmaceutical and related chemical synthesis. Publicly available material identifies the chemical families but does not provide a complete catalogue of grades, specifications, or individual product codes.

• Pharmaceutical intermediate

  Levetiracetam intermediate

  The company produces an intermediate used in the manufacture of levetiracetam, an active pharmaceutical ingredient used in treatments for epilepsy. ABA Chemicals' role is in the upstream chemical supply chain; the cited material does not indicate that it markets finished levetiracetam medicines under its own brand.

• Agrochemical chemicals

  Agrochemical and pesticide intermediates

  ABA Chemicals supplies intermediates used in pesticide manufacturing. Its acquisition of Shanghai Puyi Chemical was described as a move to consolidate and strengthen this part of the business. The public reference does not identify specific pesticide active ingredients or individual intermediate product names.

• 2020

  Regulator proposed a fine against Yaben Chemical

  Yaben Chemical said it received a prior notice of administrative penalty from the China Securities Regulatory Commission. The regulator proposed a 400,000-yuan fine against the company over misleading disclosures about its darunavir-intermediate business.

  Source

Read more

• 2017

  Acquisition of Amino ChemicalsM&A

  Background

  ABA Chemicals had an established working relationship with Dipharma, whose group included Amino Chemicals, a Malta-based pharmaceutical API-intermediate manufacturer founded in 1992.

  Action taken

  ABA Chemicals acquired Amino Chemicals, adding an overseas pharmaceutical-intermediate manufacturing business to its operations.

  Aftermath

  The acquisition strengthened ABA's pharmaceutical intermediate capabilities and broadened its international operating footprint. Specific transaction value, integration outcomes, and subsequent financial effects are not provided in the reference material.

  Source

• Acquisition of Shanghai Puyi ChemicalM&A

  Background

  ABA Chemicals sought to strengthen its position in pesticide and agrochemical manufacturing intermediates.

  Action taken

  The company acquired Shanghai Puyi Chemical.

  Aftermath

  The acquisition was described as consolidating ABA Chemicals' position in the agrochemical-intermediate market. The transaction date, value, and later operating results are not specified.

  Source

• Unconfirmed

  Reported2020.08.20

  Yaben Chemical director resignation[6]雅本化学董事辞职finance.sina.com.cn

  Yaben Chemical announced that Wang Bo had resigned as a company director and would continue as executive director of its wholly owned subsidiary, Shanghai Puyi Chemical Technology Co., Ltd.

• 2020.08.05

  Reported2020.08.06

  Regulator proposed a fine against Yaben Chemical[5]Regulator proposed a fine against Yaben Chemicalfinance.sina.com.cn

  Yaben Chemical said it received a prior notice of administrative penalty from the China Securities Regulatory Commission. The regulator proposed a 400,000-yuan fine against the company over misleading disclosures about its darunavir-intermediate business.

• Unconfirmed

  Shanghai Yaben recognized as a Shanghai specialized and innovative SME[7]上海雅本获评上海市“专精特新”中小企业hy.stock.cnfol.com

  Shanghai Yaben, a wholly owned subsidiary of Yaben Chemical, was included in the Shanghai “specialized, refined, distinctive and innovative” SME list.

Read more

1. 1ABA Chemicalsen.wikipedia.org
2. 2ABA Chemicals Corporation profile, CPhI Worldwide 2019cphi-online.com
3. 3Aba Chemicals Corp company profilereuters.com
4. 4China Ministry of Environmental Protection new chemical substance notification referencecirs-group.com
5. 5Regulator proposed a fine against Yaben Chemicalfinance.sina.com.cn
6. 6雅本化学董事辞职finance.sina.com.cn
7. 7上海雅本获评上海市“专精特新”中小企业hy.stock.cnfol.com